←Back to Expert Scholars
Translational Medicine / 转化医学HER2 Ultra-Low
Hope Rugo
MD
🏢City of Hope / UCSF🌐USA
Director, Breast Oncology and Clinical Trials Education
78
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Hope Rugo is a globally recognized breast cancer trialist who contributed to DESTINY-Breast06 ultra-low subset analyses. Her research spans HER2, TROP2 and other ADC targets in metastatic breast cancer. She has led numerous practice-changing registrational trials.
Share:
🧪Research Fields 研究领域
Metastatic breast cancer
HER2 therapies
ADCs
Sacituzumab govitecan
Supportive care
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Hope Rugo 的研究动态
Follow Hope Rugo's research updates
留下邮箱，当我们发布与 Hope Rugo（City of Hope / UCSF）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment